These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5799193)

  • 21. Proton magnetic resonance spectroscopic method for determination of phenylbutazone and oxyphenbutazone in tablets.
    Husain S; Kifayatullah M; Rao RN
    J Assoc Off Anal Chem; 1988; 71(3):525-7. PubMed ID: 3391955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on drug metabolism. IV. Effects of high dose administration of pentobarbital and phenylbutazone on the plasma biologic half lives in various species.
    Kitagawa H; Kamataki T; Yoshida S
    Chem Pharm Bull (Tokyo); 1968 Dec; 16(12):2320-3. PubMed ID: 4975994
    [No Abstract]   [Full Text] [Related]  

  • 23. Phenylbutazone in racing greyhounds: plasma and urinary residues 24 and 48 hours after a single intravenous administration.
    Mills PC; Ng JC; Skelton KV; Seawright AA; Auer DE
    Aust Vet J; 1995 Aug; 72(8):304-8. PubMed ID: 8579562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of phenylbutazone and oxyphenbutazone on basic drug detection in high performance thin layer chromatographic systems.
    Woods WE; Chay S; Houston T; Blake JW; Tobin T
    J Vet Pharmacol Ther; 1985 Jun; 8(2):181-9. PubMed ID: 2862290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An interaction between desipramine and phenylbutazone.
    Consolo S
    J Pharm Pharmacol; 1968 Jul; 20(7):574-5. PubMed ID: 4386618
    [No Abstract]   [Full Text] [Related]  

  • 26. Determination of oxyphenbutazone and phenylbutazone by differential pulse polarography after derivatization.
    Fogg AG; Ahmed YZ
    Anal Chim Acta; 1977 Dec; 94(2):453-6. PubMed ID: 596627
    [No Abstract]   [Full Text] [Related]  

  • 27. GLC determination of gamma-hydroxyphenylbutazone in plasma.
    Midha KK; McGilveray IJ; Charette C
    J Pharm Sci; 1974 Nov; 63(11):1751-4. PubMed ID: 4427237
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption of 14C-bumadizone-Ca and 14C-phenylbutazone in isolated intestinal segments in vitro and tied-off gastrointestinal sections in vivo of rats and guinea pigs.
    Seebald H; Forth W
    Arzneimittelforschung; 1977; 27(3):624-35. PubMed ID: 577432
    [No Abstract]   [Full Text] [Related]  

  • 30. Analysis of phenylbutazone residues in horse tissues with and without enzyme-hydrolysis by LC-MS/MS.
    Boison JO; Dowling T; Johnson R; Kinar J
    Drug Test Anal; 2016 May; 8(5-6):535-8. PubMed ID: 27443208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
    Spahn H; Mutschler E
    Arzneimittelforschung; 1981; 31(3):495-9. PubMed ID: 6894379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrophotometric determination of dipyrone, phenylbutazone and oxyphenbutazone by their hydrolysis and Schiff base formation with 4-dimethylaminobenzaldehyde.
    Verma KK; Jain A; Patel N; Sanghi SK
    Farmaco Prat; 1987 Jul; 42(7):185-92. PubMed ID: 3622752
    [No Abstract]   [Full Text] [Related]  

  • 33. [A simple and precise method for the analysis of phenylbutazone and oxyphenylbutazone by bromocoulometry].
    Nikolic KI; Velasevic KR; Ruasse MF
    Ann Pharm Fr; 1985; 43(2):173-6. PubMed ID: 4091460
    [No Abstract]   [Full Text] [Related]  

  • 34. Simultaneous determination of phenylbutazone and oxyphenbutazone in plasma by high-speed liquid chromatography.
    Pound NJ; Sears RW
    J Pharm Sci; 1975 Feb; 64(2):284-7. PubMed ID: 1127584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug permeation through membranes. 3. Effect of pH and various substances on permeation of phenylbutazone through everted rat intestine and polydimethylsiloxane.
    Lovering EG; Black DB
    J Pharm Sci; 1974 May; 63(5):671-6. PubMed ID: 4829985
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of phenylpyrazolone derivatives on gastric emptying rate and drug absorption in rats.
    Takanaka A; Onoda K; Kainuma E; Lienard F; Omori Y
    Jpn J Pharmacol; 1973 Oct; 23(5):745-7. PubMed ID: 4543636
    [No Abstract]   [Full Text] [Related]  

  • 37. Analysis of phenylbutazone and its metabolites by high performance liquid chromatography.
    Taylor JB; Lees P; Gerring EL
    Equine Vet J; 1981 Jul; 13(3):201-3. PubMed ID: 7297550
    [No Abstract]   [Full Text] [Related]  

  • 38. Separation of furosemide, phenylbutazone and oxyphenbutazone in plasma by direct injection onto internal surface reversed-phase columns with systematic optimization of selectivity.
    Pinkerton TC; Perry JA; Rateike JD
    J Chromatogr; 1986 Oct; 367(2):412-8. PubMed ID: 3782354
    [No Abstract]   [Full Text] [Related]  

  • 39. [Species specific difference in binding to plasma proteins].
    Kurz H; Friemel G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):35-6. PubMed ID: 4231849
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.